Ireland - English - HPRA (Health Products Regulatory Authority)

roche products (ireland) ltd - levodopa; benserazide - capsule, hard - 200 mg/50 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion. fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see clinical pharmacology). fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets are contraindicated in patients with known hypersensitivity to any of its ingredients. due to its pseudoephedrine component, fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets are contraindicated in patients with narrow-angle glaucoma or urin

Ireland - English - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - paracetamol; guaifenesin; phenylephrine hydrochloride - capsule, hard - 500 mg/100 mg/6.1 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Ireland - English - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - paracetamol; guaifenesin; phenylephrine hydrochloride - capsule, hard - 500 milligram(s) - paracetamol, combinations excl. psycholeptics

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg - hypertension. methyldopa is contraindicated in patients:

United States - English - NLM (National Library of Medicine)

mylan institutional inc. - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 500 mg - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see warnings). - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - levodopa, benserazide hydrochloride - capsule - levodopa 50 mg benserazide hydrochloride 12.5 mg - anti-parkinson drugs

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - levodopa, benserazide hydrochloride - capsule - levodopa 50 mg benserazide hydrochloride 12.5 mg - anti-parkinson drugs

Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - levodopa, quantity: 200 mg; benserazide hydrochloride, quantity: 57 mg (equivalent: benserazide, qty 50 mg) - capsule, hard - excipient ingredients: iron oxide yellow; magnesium stearate; indigo carmine; povidone; gelatin; titanium dioxide; purified talc; microcrystalline cellulose; iron oxide red - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

Ireland - English - HPRA (Health Products Regulatory Authority)

wrafton laboratories ltd. t/a perrigo - paracetamol; guaifenesin; phenylephrine hydrochloride - capsule, hard - 500/100/6.1 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics